Holen Sie sich die Stockscreener-App
152.65
0.96%
1.45
Handel nachbörslich:
152.65
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$151.20
Offen:
$151.31
24-Stunden-Volumen:
1.10M
Relative Volume:
1.38
Marktkapitalisierung:
$17.04B
Einnahmen:
$9.54B
Nettoeinkommen (Verlust:
$841.00M
KGV:
20.52
EPS:
7.44
Netto-Cashflow:
$1.02B
1W Leistung:
-0.22%
1M Leistung:
-0.29%
6M Leistung:
+4.55%
1J Leistung:
+15.15%
1-Tages-Spanne:
$150.80
$152.99
1-Wochen-Bereich:
$148.70
$154.44
52-Wochen-Spanne:
$123.04
$165.32
Quest Diagnostics Inc Stock (DGX) Company Profile
Firmenname
Quest Diagnostics Inc
Sektor
Branche
Telefon
(973) 520-2700
Adresse
500 PLAZA DRIVE, SECAUCUS
Vergleichen Sie DGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
152.65 | 17.04B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
573.06 | 219.20B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
244.11 | 176.31B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
152.57 | 43.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
205.69 | 37.33B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
427.33 | 34.99B | 3.84B | 866.24M | 792.60M | 10.37 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Fortgesetzt | Evercore ISI | In-line |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-29 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-01-23 | Eingeleitet | Evercore ISI | In-line |
| 2022-11-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-23 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-02 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Hochstufung | Argus | Hold → Buy |
| 2020-07-29 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-09 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Herabstufung | Goldman | Neutral → Sell |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-03-18 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-01-31 | Herabstufung | Argus | Buy → Hold |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics Incorporated (NYSE:DGX) Position Boosted by UMB Bank n.a. - MarketBeat
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Increases By 6.3% - MarketBeat
9,488 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Avanza Fonder AB - MarketBeat
DGX (Quest Diagnostics) Operating Income : $1,252 Mil (TTM As of Sep. 2024) - GuruFocus.com
Wedge Capital Management L L P NC Decreases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Assenagon Asset Management S.A. Purchases 108,224 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Stock Position Raised by Occidental Asset Management LLC - MarketBeat
Miracle Mile Advisors LLC Takes $291,000 Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Yahoo Finance
Earnings Preview: What to Expect From Quest Diagnostics' Report - MSN
Revenue Cycle Management (RCM) Market Size is Expected to Reach USD 873.74 by 2033, Growing at a CAGR of 11%: Straits Research - GlobeNewswire Inc.
Sawyer & Company Inc Sells 2,168 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Gets Meta Data-Share Suit Tossed For Now - Law360
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Quest Diagnostics Wins Dismissal of Suit Over Meta Info Sharing - Bloomberg Law
Earnings Preview: What To Expect From Quest Diagnostics' Report - Barchart
Oak Thistle LLC Increases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Downgraded by StockNews.com to "Hold" - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Clean Yield Group Purchases 3,983 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Relationship Genetic Tests Market Report 2024, Featuring - GlobeNewswire
Relationship Genetic Tests Market Report 2024, Featuring Profiles of Laboratory Corporation of America, Quest Diagnostics, Cleveland Clinic, Myriad Genetics, Invitae and More - Yahoo Finance
Zacks Research Has Bullish Outlook for DGX FY2025 Earnings - MarketBeat
Ex-Dividend Reminder: Universal Corp, Shoe Carnival and Quest Diagnostics - Nasdaq
Alzheimer's Disease Diagnostics Research Report 2024-2034: Global Market to Reach $27.87 Billion - GlobeNewswire Inc.
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Employee Shares How Music Career Led to Healthcare Logistics Success - StockTitan
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer - Financial Times
Nordea Investment Management AB Sells 13,456 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
Quest Diagnostics Inc. stock rises Monday, still underperforms market - MarketWatch
Leerink Partners Upgrades Quest Diagnostics (DGX) - MSN
Quest Diagnostics (NYSE:DGX) Upgraded to "Outperform" at Leerink Partners - MarketBeat
Quest Diagnostics upgraded by Leerink Partners with a new price target - Quantisnow
Quest Diagnostics (NYSE:DGX) shareholders have earned a 9.4% CAGR over the last five years - Simply Wall St
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again - Yahoo Finance
OhioHealth outsourcing some lab work to Quest Diagnostics - The Business Journals
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 - Longview News-Journal
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Should You Hold Quest Diagnostics Stock in Your Portfolio Now? - MSN
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? - MSN
How Is The Market Feeling About Quest Diagnostics? - Benzinga
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Declines By 6.4% - MarketBeat
JPMorgan Chase & Co. Sells 18,505 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Lobbying Update: QUEST DIAGNOSTICS INCORPORATED just disclosed $80,000 of lobbying spending - Nasdaq
Quest Diagnostics Incorporated (NYSE:DGX) Receives $169.15 Average PT from Brokerages - MarketBeat
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Finanzdaten der Quest Diagnostics Inc-Aktie (DGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):